نویسندگان | Hossein Javdani,Farzaneh Karimi,Shiva Mahmoudi,Ali Farahi,Mohamad Javad Mirzaei-Parsa,Arman Shahabi |
---|---|
نشریه | Molecular Biology Reports |
شماره صفحات | 9963-9973 |
شماره سریال | 49 |
نوع مقاله | Full Paper |
تاریخ انتشار | 2022 |
نوع نشریه | چاپی |
کشور محل چاپ | هلند |
نمایه نشریه | ISI،JCR،Scopus |
چکیده مقاله
Despite major advances, breast cancer (BC) is the most commonly diagnosed carcinoma and remains a deadly disease among women worldwide. Many researchers point toward an important role of an epithelial to mesenchymal transition (EMT) in BC development and promoting metastasis. Here, will be discussed that how functional changes of transcription factors, signaling pathways, and microRNAs (miRNA) in BC promote EMT. A thorough understanding the EMT biology can be important to determine reversing the process and design treatment approaches. There are frequent debates as to whether EMT is really relevant to BC in vivo, in which due to the intrinsic heterogeneity and tumor microenvironment. Nevertheless, given the importance of EMT in cancer progression and metastasis, the implementation of therapies against cancer-associated EMT will continue to help us develop and test potential treatments.
tags: Epithelial-mesenchymal transition. MicroRNAs. Breast cancer. Metastasis. cancer therapy